Provided by Tiger Trade Technology Pte. Ltd.

Shuttle Pharmaceuticals Inc

1.11
+0.08007.77%
Post-market: 1.120.0100+0.90%19:58 EST
Volume:108.96K
Turnover:119.16K
Market Cap:3.61M
PE:-0.32
High:1.17
Open:1.03
Low:1.03
Close:1.03
52wk High:17.70
52wk Low:1.03
Shares:3.25M
Float Shares:3.23M
Volume Ratio:0.46
T/O Rate:3.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4200
EPS(LYR):-79.6550
ROE:-27176.19%
ROA:-323.31%
PB:2.59
PE(LYR):-0.01

Loading ...

Shuttle Pharmaceuticals Extends Consulting Agreement With Interim Co-CEO at $20,000 Per Month

Reuters
·
Feb 03

Shuttle Pharmaceuticals Names Yuying Liang as Finance Chief

Dow Jones
·
Jan 13

BRIEF-Shuttle Pharmaceuticals Holdings Inc - Appoints Yuying Liang As CFO - SEC Filing

Reuters
·
Jan 13

Shuttle Pharmaceuticals Holdings Inc. Files Initial Beneficial Ownership Statement for CFO Yuying Liang

Reuters
·
Jan 13

Shuttle Pharmaceuticals Issues 320,496 Unregistered Shares in Asset Purchase Deal

Reuters
·
Dec 30, 2025

BRIEF-Shuttle Pharmaceuticals Holdings Inc - Timothy Lorber Resigns As CFO Of Shuttle Pharmaceuticals - SEC Filing

Reuters
·
Nov 29, 2025

Shuttle Pharmaceuticals Holdings Inc - Timothy Lorber Resigns as CFO of Shuttle Pharmaceuticals - SEC Filing

THOMSON REUTERS
·
Nov 29, 2025

Shuttle Pharmaceuticals Holdings Inc - Cooper Will Serve in This Capacity While Com Conducts Search for Permanent CFO

THOMSON REUTERS
·
Nov 29, 2025

Shuttle Pharmaceuticals Names Christopher Cooper as Interim CFO

Reuters
·
Nov 29, 2025

Shuttle Pharmaceuticals Announces Unregistered Sale of Common Stock

Reuters
·
Nov 27, 2025

Stocks to Watch: Shuttle Pharma, Butterfly Network, Captivision

Dow Jones
·
Nov 22, 2025

Shuttle Pharmaceuticals Halts Ropidoxuridine Clinical Trials Amid Reorganization

Reuters
·
Nov 22, 2025

Shuttle Pharmaceuticals Closes Acquisition of Molecule.ai for $8 Million

Reuters
·
Nov 21, 2025

Lendway Shares Jump Nearly 20% After Hours — Here's Why

Benzinga_recent_news
·
Nov 21, 2025

Why Shuttle Pharmaceuticals (SHPH) Stock Surged Overnight?

Benzinga_recent_news
·
Nov 21, 2025

Shuttle Pharmaceuticals Faces Nasdaq Delisting Risk Over Equity Shortfall

Reuters
·
Nov 18, 2025

Shuttle Pharmaceuticals Q3 EPS $(1.05) Up From $(39.75) YoY

Benzinga
·
Nov 14, 2025

Shuttle Pharmaceuticals Raises $2.5 Million in Private Placement of Pre-Funded Warrants

Reuters
·
Nov 08, 2025

Shuttle Pharmaceuticals Raises $2.5 Million in Private Placement at $4.00 Per Share

Reuters
·
Nov 03, 2025

Shuttle Pharmaceuticals Holdings Inc. Files Initial Beneficial Ownership Statement for Director Angel Liriano

Reuters
·
Oct 30, 2025